Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs.
about
Pharmacological treatment of PTSD - established and new approachesInteroception and stress.Overlap between atypical depression, seasonal affective disorder and chronic fatigue syndromeChronic activation of corticotropin-releasing factor type 2 receptors reveals a key role for 5-HT1A receptor responsiveness in mediating behavioral and serotonergic responses to stressful challenge.Chronic fatigue syndrome: new insights and old ignorance.Transgenic models for cytokine-induced neurological disease.Dysthymia: a review of pharmacological and behavioral factors.Clinical subtypes of depression are associated with specific metabolic parameters and circadian endocrine profiles in women: the power studyHypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome.Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states.Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attemptsPossible use of repeated cold stress for reducing fatigue in chronic fatigue syndrome: a hypothesis.Low-dose dexamethasone challenge in women with atypical major depression: pilot study.Antidepressants and neuroplasticity.In search of HPA axis dysregulation in child and adolescent depression.Brain systems underlying susceptibility to helplessness and depression.Modulation of stress consequences by hippocampal monoaminergic, glutamatergic and nitrergic neurotransmitter systems.HPA axis and sleep: identifying subtypes of major depression.Role of insulin metabolism disturbances in the development of Alzheimer disease: mini review.Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neuronsEscitalopram alters gene expression and HPA axis reactivity in rats following chronic overexpression of corticotropin-releasing factor from the central amygdala.Placental Corticotropin-Releasing Hormone Mediates the Association Between Prenatal Social Support and Postpartum Depression.Incorporating hypothalamic-pituitary-adrenal axis measures into preventive interventions for adolescent depression: are we there yet?Recent depressive and anxious symptoms predict cortisol responses to stress in menReducing the Burden of Difficult-to-Treat Major Depressive Disorder: Revisiting Monoamine Oxidase Inhibitor Therapy.Melancholia in Latin American studies: a distinct mood disorder for the ICD-11.Stress, immunity, cytokines and depression.Abnormalities of the HPA axis in affective disorders: clinical subtypes and potential treatments.The 1microg short Synacthen test in chronic fatigue syndrome.Functional but not structural subgenual prefrontal cortex abnormalities in melancholia.Effects of acute or 3-day treatments of Hypericum caprifoliatum Cham. & Schltdt. (Guttiferae) extract or of two established antidepressants on basal and stress-induced increase in serum and brain corticosterone levels.Maternal and environmental factors influence the hypothalamic-pituitary-adrenal axis response to corticotropin-releasing hormone infusion in offspring of mothers with or without mood disorders.Two forms of self-criticism mediate differently the shame-psychopathological symptoms link.Blunted adrenocorticotropin and cortisol responses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome.Glucocorticoids and glucocorticoid receptors: mediators of fatigue?Circadian activity of the hypothalamic-pituitary-adrenal axis is differentially affected in the rat chronic mild stress model of depression.Subtypes of depression and their overlap in a naturalistic inpatient sample of major depressive disorder.
P2860
Q24633256-6A5C90DE-D384-41B2-B4C6-B783999088F6Q26800189-D22F3B5C-2442-4B40-B061-CE52CA5FAC48Q28304950-AC439592-C08B-401C-9770-52DE0DA5A1B9Q30524485-22934638-19CE-4593-A22D-39BABA5A0B11Q33785889-262C1ED7-F28C-45F3-A3E0-C984D62E86E1Q33926168-72448601-1E0E-46BB-A662-4A4B76F395FEQ33964349-9E00E6D8-B981-4775-9653-232052A163E6Q34123494-59508023-BEB5-48B1-89F7-3CA4686600CEQ34219361-20BDEB25-A1A5-44FD-BBDA-188B89B38100Q34580335-CB9C3DA4-24F7-4794-8D1D-36E35C7925C9Q34594318-427A3092-336B-4505-8C1A-A02062C3FF19Q34706465-0EA52027-AB16-4DAA-B411-83E320A42BEAQ34758357-E7122DAF-309D-45AC-9C5E-D1656A8EFA35Q34785757-4FFB86A5-BCA5-4B64-B6AC-C14D22226633Q34984994-EDE28F0B-EC2F-400D-8308-9A20DA2A1430Q35684600-07FB42A9-06A8-4752-8E1D-3DECE67B0E80Q36871849-9B185B64-0120-4505-A81D-6F24B8C5E3D4Q36939724-A94F2F8B-1D2D-45D8-AD65-6760CC185398Q37058255-2C5E19A6-878E-4001-815F-B681FCFB342DQ37066736-149D3E36-AC41-4CC0-91DA-323657397AD7Q37109740-9765EAA6-58BF-4F6E-ADB5-08740EC85ADDQ37130488-1E27F07B-16D1-4129-A94A-751D014A05DFQ37208947-19E1199A-316D-4E49-AAB1-CF216B431093Q37354464-A5314479-2142-4349-A76A-9E8FD55A6ED4Q37533875-73B1F0EC-60B2-4777-9373-FC099B3F8908Q37918426-610C3768-E914-43CA-B572-66C6AA167B75Q38777658-4073F635-6359-4215-9678-6B0B62159E23Q38779494-F9ABE365-CA4B-42BA-9E7C-F0EB1F33E37EQ40786489-FB9A6D5F-CF95-4B90-8557-38DE9B318044Q44709363-B83AFEFB-15B7-4488-A062-199A46AF41F5Q46727021-1AD315A2-6BE5-4207-B210-A6B84B621262Q46944766-D8441D36-8524-4EA6-B0B6-9B391D0D47D7Q47425021-EB488132-9A5A-483E-AE08-62523BBBB1BDQ47821608-CC760CF5-FB9E-4AF7-808F-0ED883B05407Q48609845-11D2A0C1-475E-4569-B916-DE8F339BAC9AQ48729354-C27C59B3-2F7B-434C-A72E-366A8AADA3C9Q52808722-1F221F01-7002-4867-85F9-C01DF6C710FB
P2860
Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Corticotropin releasing hormon ...... ction of antidepressant drugs.
@en
type
label
Corticotropin releasing hormon ...... ction of antidepressant drugs.
@en
prefLabel
Corticotropin releasing hormon ...... ction of antidepressant drugs.
@en
P2860
P1476
Corticotropin releasing hormon ...... ction of antidepressant drugs.
@en
P2093
P2860
P304
P356
10.1111/J.1749-6632.1995.TB44723.X
P407
P577
1995-12-01T00:00:00Z